Kevin E Kip
Overview
Explore the profile of Kevin E Kip including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
4589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saeed A, McKennan C, Duan J, Yang Y, Kip K, Finegold D, et al.
EBioMedicine
. 2025 Jan;
112:105551.
PMID: 39793479
Background: Preclinical data have shown that low levels of metabolites with anti-inflammatory properties may impact metabolic disease processes. However, the association between mid-life levels of such metabolites and long-term ASCVD...
2.
Lengacher C, Hueluer G, Wang J, Reich R, Meng H, Park J, et al.
J Integr Complement Med
. 2024 Dec;
PMID: 39711191
Trial Registration: ClinicalTrials.gov, www. Clinicaltrials: gov. Registration Number: NCT02786797.
3.
Park J, Lengacher C, Rodriguez C, Meng H, Kip K, Morgan S, et al.
Biol Res Nurs
. 2024 Oct;
27(2):216-228.
PMID: 39413359
Background: Genetics may influence symptoms experienced by breast cancer survivors (BCS) by moderating the effects of stress-reducing interventions, including the Mindfulness-Based Stress Reduction (MBSR(BC)) program, to reduce symptom severity. As...
4.
Lengacher C, Reich R, Rodriguez C, Nguyen A, Park J, Meng H, et al.
J Integr Complement Med
. 2024 Sep;
31(1):75-91.
PMID: 39291332
The Mindfulness-Based Stress Reduction (MBSR) Program for breast cancer survivors (BCS) is designed to enhance cognitive training through formal and informal meditational practices. This randomized clinical trial (RCT) aimed to...
5.
Diamond D, Kip K
Lancet Diabetes Endocrinol
. 2024 Aug;
12(9):612-613.
PMID: 39174155
No abstract available.
6.
Kip K, Diamond D, Mulukutla S, Marroquin O
BMJ Open
. 2024 Mar;
14(3):e077949.
PMID: 38548371
Objectives: Among primary prevention-type adults not on lipid-lowering therapy, conflicting results exist on the relationship between low-density lipoprotein cholesterol (LDL-C) and long-term mortality. We evaluated this relationship in a real-world...
7.
Kip K, McCreary E, Collins K, Minnier T, Snyder G, Garrard W, et al.
Ann Intern Med
. 2023 Apr;
176(4):496-504.
PMID: 37011399
Background: Treatment guidelines and U.S. Food and Drug Administration emergency use authorizations (EUAs) of monoclonal antibodies (mAbs) for treatment of high-risk outpatients with mild to moderate COVID-19 changed frequently as...
8.
Panza E, Kip K, Venkatakrishnan K, Marroquin O, Wing R
Acta Diabetol
. 2023 Mar;
60(6):787-795.
PMID: 36894712
Aims: To examine the association between COVID-19 Shutdown and within-subjects changes in body weight, body mass index (BMI), and glycemic parameters using electronic health record (EHR) data from 23,000 adults...
9.
McCreary E, Kip K, Collins K, Minnier T, Snyder G, Steiner A, et al.
Open Forum Infect Dis
. 2022 Nov;
9(10):ofac517.
PMID: 36324319
Background: Monoclonal antibody (mAb) treatment is associated with decreased risk of hospitalization and death in high-risk outpatients with mild to moderate coronavirus disease 2019 (COVID-19) caused by early severe acute...
10.
Berkowitz J, Khetpal V, Echouffo-Tcheugui J, Bambs C, Aiyer A, Kip K, et al.
Am J Prev Cardiol
. 2022 Aug;
11:100367.
PMID: 35923764
Background: Limited studies have assessed the effects of psychosocial risk factors on achievement of ideal cardiovascular health . Methods: Using the Heart Strategies Concentrating on Risk Evaluation (HeartSCORE) cohort, we...